Femme Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the efficacy and tolerance of the association of two drugs already marketed and used to treat your disease: Arimidex® 1 Mg per day per os and Zoladex® 3,6 Mg in injections under cutaneous once per month in subjects with breast cancer.
Critère d'inclusion
- Breast Cancer